Profile data is unavailable for this security.
About the company
Ste Promotion Pharmaceutique du Maghreb SA, formerly known as Promopharm SA, is a Morocco-based company engaged in the pharmaceutical sector. It specializes in the production, marketing, import and export of pharmaceuticals, Para pharmaceuticals, dermo pharmaceuticals and cosmetics. In addition, the Company is involved in various types of industrial, commercial, financial, real estate and other operations related to its business. It also ensures the production and distribution of high-end dermo cosmetic products and manufactures, as a subcontractor, medicines on behalf of national and international laboratories.
- Revenue in MAD (TTM)928.99m
- Net income in MAD57.20m
- Incorporated1947
- Employees--
- LocationSte Promotion Pharmaceutique du Maghreb SARue 7. zone industrielle du SahelBp 96/97, BerrechidHAD SOUALEM 26400MoroccoMAR
- Phone+212 522964567
- Fax+212 522964701
- Websitehttps://www.promopharm.co.ma
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Group Ltd | 2.68bn | -584.49m | 1.40bn | 450.00 | -- | 0.5815 | -- | 0.5213 | -1.14 | -1.19 | 5.22 | 4.56 | 0.3828 | 2.57 | 2.42 | 917,797.80 | -8.35 | -15.32 | -11.61 | -20.87 | 61.06 | 53.04 | -21.81 | -64.51 | 1.16 | -- | 0.1003 | -- | 4.44 | -2.04 | 46.58 | -- | -9.26 | -- |
| Renascience Inc | 6.32m | -15.30m | 1.40bn | 3.00 | -- | 9.62 | -- | 221.78 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| NDT Pharmaceuticals Inc | -916.10bn | -916.10bn | 1.41bn | 1.00 | -- | 0.8576 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Ste Promotion Pharmaceutique du Mghrb SA | 928.99m | 57.20m | 1.44bn | -- | 25.09 | 2.49 | 12.51 | 1.54 | 57.20 | 57.20 | 928.99 | 575.64 | 0.7791 | 1.38 | 3.90 | -- | 4.80 | 8.48 | 7.50 | 12.35 | 44.33 | 48.51 | 6.16 | 8.76 | 0.9687 | 16.40 | 0.2975 | -- | 11.57 | 11.46 | -3.05 | 1.14 | 44.62 | -- |
| Kotra Industries Berhad | 540.46m | 98.51m | 1.44bn | 713.00 | 14.67 | 2.19 | 11.04 | 2.67 | 0.283 | 0.283 | 1.55 | 1.89 | 0.6767 | -- | 6.51 | 322,946.70 | 12.33 | 15.69 | 14.64 | 18.97 | -- | 74.23 | 18.23 | 22.38 | 1.68 | 1,900.70 | 0.0797 | 53.35 | 1.87 | 6.09 | -4.76 | 7.52 | 72.15 | 23.16 |
| IX Biopharma Ltd | 52.28m | -43.01m | 1.46bn | 56.00 | -- | 48.67 | -- | 27.90 | -0.0067 | -0.0067 | 0.0081 | 0.0043 | 0.4991 | 5.46 | 4.11 | -- | -41.06 | -42.93 | -85.83 | -63.02 | 28.05 | 48.40 | -82.27 | -121.27 | 0.9439 | -16.59 | 0.6196 | -- | 30.34 | 51.13 | 6.05 | -- | -27.36 | -- |
| T Man Pharmaceutical PCL | 694.29m | 132.54m | 1.46bn | 960.00 | 11.04 | 2.56 | 8.72 | 2.11 | 1.12 | 1.12 | 5.88 | 4.84 | 0.754 | 2.03 | 3.64 | 2,452,049.00 | 14.40 | -- | 33.57 | -- | 47.67 | -- | 19.09 | -- | 0.9128 | 17.38 | 0.3316 | -- | 12.19 | -- | 4.55 | -- | -- | -- |
| Ngl Fine Chem Ltd | 451.21m | 35.72m | 1.46bn | 456.00 | 40.98 | -- | 27.24 | 3.24 | 57.26 | 57.26 | 723.35 | -- | -- | -- | -- | 9,799,871.00 | -- | 13.34 | -- | 17.44 | 51.62 | 41.63 | 7.92 | 12.15 | -- | 9.06 | -- | 2.85 | 8.73 | 19.41 | -48.87 | 20.44 | 53.91 | 0.00 |
| Cenra Inc | 2.52bn | 85.37m | 1.48bn | 1.40k | 12.30 | 0.6663 | 7.97 | 0.5847 | 2.76 | 2.76 | 78.36 | 50.88 | 0.6976 | 1.98 | 5.75 | -- | 2.37 | 3.49 | 3.58 | 4.70 | 38.96 | 36.76 | 3.39 | 5.22 | 0.7294 | 6.48 | 0.294 | 50.31 | 4.01 | 2.28 | -1.53 | -3.78 | -8.43 | 4.92 |
Data as of Feb 13 2026. Currency figures normalised to Ste Promotion Pharmaceutique du Maghreb SA's reporting currency: Moroccan Dirham MAD
